Xelpmoc Design and Tech Ltd

AGM Details

• AGM held on 30 September 2026 at 3:00 PM via VC/OAVM.
• Quorum: 39 members present through VC; physical attendance dispensed.
• Remote e-voting and Insta Poll used; voting period 26–29 September 2026.
• Scrutinizer appointed: Manish Gupta, Practicing Company Secretary.
• Notice, annual report sent; meeting conducted per MCA/SEBI circulars.

Key Resolutions

• Adoption of audited standalone and consolidated financials for FY2026; ordinary resolution; passed.
• Appointment of Jaison Jose as director; ordinary resolution; passed.
• Approval for ESOP-2026 Scheme; special resolution; passed.
• Extend ESOP 2026 to subsidiary employees; special resolution; passed.
• Grant of ESOP 2020 options to identified employees (≥1% of issued capital); special resolution; passed.
• Grant of ESOP 2026 options to identified employees (≥1%); special resolution; passed.

Director Changes

• Director Jaison Jose re-appointed; retires by rotation.

Auditors

• Statutory and secretarial auditors attended; no appointment change announced.

Xelpmoc Design and Tech Ltd trading window closed from Sept 30, 2026 at 5:00 PM until 48 hours after the Q2 and H1 2026 results are announced

ESOP grant details

• Nomination and Remuneration Committee approved grant of 1,45,000 options under ESOP 2020.
• Total options cover 1,45,000 equity shares of Rs 10 face value.
• Vesting starts after one year and will vest over three years in 33:33:34 ratio.
• Exercise price is Rs 10 per option under SBEB Regulations 2021 and ESOP Scheme 2020.
• Exercise period will be up to seven years from vesting date.

Share allotment under ESOS

• 8,400 equity shares allotted to employees under ESOS 2019 at Rs 10 per share.
• Money realized from exercise: Rs 84,000.
• Post-allotment paid-up capital increased to Rs 14,83,07,210 with 1,48,30,721 shares.

Disposal of Woovly investment

• Audit Committee and Board approved the sale of equity shares in Woovly India Private Limited.
• Total consideration for the disposal is Rs 14,58,36,810 per valuation report.
• Valuation report obtained from a registered valuer.

FY26 snapshot

• FY26 revenue from operations ₹37,353.38k; down 4.25% YoY.
• Corporate engagements accounted for 100% of FY26 revenue.
• Launched proprietary platforms DocuXray and RELY; momentum building.
• 65 clients served; team size 63.
• Partial Mihup exit realized ₹100 million.
• Portfolio fair value rose to ₹726.8m from ₹615.4m.
• DocuXray extraction accuracy above 98%; ~70% lower manual effort.
• Woovly EBITDA positive; Mihup and Star In Me progressed.
• FY26: enterprise focus driving execution.

Financial performance

• Adj Operating EBITDA: -₹63,000k; improved from -₹73,200k.
• Net loss: -₹74,189k; narrowed from -₹86,195k.
• Total comprehensive income: ₹100,530k.
• Runway ~10–12 months; path to EBITDA break-even.
• No borrowings; debt-free status achieved.
• Cash and cash around ₹9,276k (standalone).
• Dividend: no dividend declared for FY26.

Proprietary products & portfolio

• DocuXray: AI platform for document processing; extraction accuracy above 98%; ~70% lower manual effort.
• RELY: AgeTech platform; initial product-market fit; deployed in western India.
• VideoXray in development; expands in-house product portfolio.
• Two proprietary platforms to generate recurring enterprise revenue.

Go-to-market & engagements

• GTM: partner-led with revenue sharing; tests demand before scaling.
• Mihup partial exit and Woovly progress highlighted; Star In Me recognized.
• Mihup contracted value exceeded ₹1,000m; Woovly ARR US$4.1m.

Capital structure & liquidity

• Equity capital rose to ₹14,759.493k; 39,500 ESOPs exercised.
• Dividend policy disclosed online; no dividend declared FY26.
• Subsidiaries: Signal Analytics; Soultrax; Xelpmoc UK dissolved; Xperience associate.

Governance & risk management

• Board: 6 directors; 2 independent; 5 meetings; independent meeting on 25 Mar 2026.
• Statutory auditors: JHS & Associates; Secretarial: VKMG; Internal: Venu & Vinay.
• Labour Code 2020: exceptional item; monitoring final rules.

Outlook & risks

• FY27 focus: scale DocuXray and RELY; convert pipeline; reach EBITDA profitability.
• Enterprise AI adoption cycles remain long; emphasize private, secure deployments.
• Regulatory risks include Labour Codes and DPDP; potential cost impact.
• Outlook: disciplined execution; portfolio-driven growth; governance strengthened.